Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NetraMark Holdings Inc C.AIAI

Alternate Symbol(s):  AINMF

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.


CSE:AIAI - Post by User

Post by partystockeron Mar 01, 2022 9:42am
197 Views
Post# 34470677

$MEND.c Launches Its New Mental Wellbeing App, Nuro

$MEND.c Launches Its New Mental Wellbeing App, Nuro

Nurosene (CSE: MEND) has made a big move today with the launch of its new Nuro app, designed to improve and advance mental well-being. 


The App targets massive industry verticals such as Health & Wellness ($1.5T market), Performance ($10B by 2025), Self-Improvement ($14B by 2025), and Mental Health (264M+ affected globally).


$MEND.c shares are currently on a bounce from all-time lows, up 34% to date. This application launch should prove as a strong catalyst for shares going forward. I expect to hear reports on user acquisition and projected revenue in the coming months to be the biggest driver for share prices. 


$MEND.c is currently trading at $.68 and is valued at $27.29 million. 


https://www.newswire.ca/news-releases/nurosene-advances-brain-health-with-the-launch-of-its-science-first-nuro-app-806224356.html

 
<< Previous
Bullboard Posts
Next >>